Skip to main content
. Author manuscript; available in PMC: 2014 May 1.
Published in final edited form as: Genet Med. 2012 Dec 6;15(5):361–367. doi: 10.1038/gim.2012.109

Table 2.

PD risk prediction regression estimates by model using the training set

Model 1
Model 2
Model 3a
Model 4b
Model 5a
Covariate OR
(95% CI)
P value OR
(95% CI)
P value OR
(95% CI)
P value OR
(95% CI)
P value OR
(95% CI)
P value
Age 1.01
0.99–1.02
0.182 1.01
0.98–1.00
0.26 1.01
0.99–1.02
0.13 1.01
0.99–1.02
0.12 1.01
0.99–1.02
0.12
Male sex 3.29
2.52–4.31
<0.001 3.39
2.58–4.45
<0.001 3.20
2.44–4.19
<0.001 3.21
2.43–4.24
<0.001 3.28
2.49–4.32
<0.001
Smoking 0.91
0.69–1.18
0.469 0.92
0. 70–1.21
0.54 0.90
0.69–1.18
0.003 0.91
0.69–1.20
0.50 0.92
0.69–1.22
0.52
Risk allele score



2.57
1.72–3.83
<0.001 2.62
2.07–3.30
<0.001 2.39
1.60–3.59
<0.001
Family history: unknown

1.35
0.88–2.09
0.16



1.28
0.83–1.97
0.27
Family history: first degree

3.59
1.94–6.64
<0.001



3.39
1.81–6.28
<0.001
Family history: second
degree


3.25
1.67–6.32
0.001



3.19
1.60–6.25
0.001
Family history: third
degree


2.07
0.68–6.32
0.20



1.88
0.61–5.83
0.28

CI, confidence interval; OR, odds ratio; PD, Parkinson disease; SNP, single-nucleotide polymorphism.

a

Included four SNPs: SNCA rs11931074, SNCA rs356220, MAPT rs1800547, and the LRRK2 G2019S mutation (rs34637584).

b

Included all 33 SNPs with known association with PD.